InsidersTradesSigma
Track the APRICUS BIOSCIENCES, INC. share price and the full insider trade history of the company, a listed issuer based in United States. Shares are quoted on US US, under the supervision of SEC (Form 4). Market capitalisation: €1.8bn. The latest transaction was disclosed on 14 January 2016 (Acquisition). Among the most active insiders: DENNER ALEXANDER J. All data is openly available.
Analysts rate APRICUS BIOSCIENCES, INC. Strong Buy (bullish), based on 10 analysts. Average price target: US$57.10.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
1 of 1 declaration
APRICUS BIOSCIENCES, INC. is a biotechnology company focused on developing innovative treatments for specific medical conditions. It is listed on NASDAQ under the symbol APRI.